Amneal Pharmaceuticals, Inc. AMRX Increase Decrease In Due From Related Parties
Increase Decrease In Due From Related Parties at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDueFromRelatedParties.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s increase decrease in due from related parties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s increase decrease in due from related parties?
- Amneal Pharmaceuticals, Inc. (AMRX) reported increase decrease in due from related parties of $56K in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s increase decrease in due from related parties changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s increase decrease in due from related parties increased by 2700.0% year-over-year, from $2K to $56K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s increase decrease in due from related parties?
- Over 2 years (2021 to 2024), Amneal Pharmaceuticals, Inc.'s increase decrease in due from related parties has grown at a -74.6% compound annual growth rate (CAGR), from -$7.49M to -$482K.
- What does increase decrease in due from related parties mean?
- This measures the net change in short-term receivables owed to the company by affiliated entities or related parties. It tracks the liquidity impact of intercompany transactions and the timing of cash collections from these partners.